How AI is Transforming Drug Development: Reflections from AAPS - PharmSci 360 with Dr. Mark Arnold

Dr. Mark Arnold, a distinguished bioanalytical thought leader with an impressive track record in supporting drug development programs. Mark is the Owner and Principal at Bioanalytical Solution Integration, where he provides strategic counsel on complex bioanalytical assays and regulatory compliance. With over 35 years of experience, including leadership roles at BMS and Labcorp, Mark has become a key figure in the biotech and pharma industries. He is also an AAPS Fellow and a founder of the Global Bioanalysis Consortium.01:05 - Career Reflections and Contributions to Drug Development05:28 - Understanding the Integration of Drug Development09:30 - What Would You Change? Embracing Career Risks in Pharma11:32 - Navigating Career Paths: Small vs. Large Companies16:09 - NEW NEWS! - Can Electrical Fields Disrupt Cancer?23:28 - The Role of AI in Drug Development31:13 - Encouraging Innovation in a Regulated IndustryFollow Mark, Chad and Gregory:Please donate to: Samaritan’s Pursehttps://www.samaritanspurse.org/ Mark Arnold - https://www.linkedin.com/in/markearnoldphd/Blog - https://bioanalysisandbiomarkers.blogspot.com/ Dr. Chad Briscoe - https://www.linkedin.com/in/chadbriscoe/Celerion - https://www.celerion.com/Gregory Austin - https://www.linkedin.com/in/gregoryaustin1/ECI - https://eci-rx.com /BioTalk Unzipped on LinkedIn - https://www.linkedin.com/company/biotalk-unzipped/New News Story: Novocure wins FDA approval for electric field device in lung cancerhttps://www.biopharmadive.com/news/novocure-fda-lung-cancer-approval-optune-lua-tumor-treating-field/729997Two articles on finding 1000’s of dark matter RNA viruses: https://www.fiercebiotech.com/research/deep-learning-ai-model-scans-dark-matter-genomic-data-and-finds-70000-never-seen-rnahttps://www.nature.com/articles/d41586-024-03320-6Image CreditsNovocure images courtesy of Novocure: www.novocure.com